Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23–35 BMI patients
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
To assess the efficacy of ileal transposition with sleeve gastrectomy (SGIT) surgery in remission of Type 2 Diabetes Mellitus (T2DM) in patients with 23–35 BMI. Diabetes is considered a life style disease. Despite medications and lifestyle changes, (HbA1c) - remains > 7 in 56 % of diabetics, predisposing them to high risk of diabetes related complications. Bariatric surgery results in remission of diabetes in over 84% patients with BMI > 35 m2s/m2. Based on hindgut hypothesis suggesting role of incretins like GLP-1, early trials of ileal interposition surgery have displayed consistent HbA1c levels below 7 in over 80% patients with BMI > 30 m2/m2. In developing countries majority of T2DM patients are not morbidly obese and surgical procedures are to be evaluated for their efficacy in this group. In this study we have assessed the efficacy of ileal transposition with sleeve gastrectomy (SGIT) in 23–35 BMI T2DM patients. Selected T2DM patients [HbA1c > 7, C Peptide > -1 ng/ml] underwent Lap SGIT by a single surgeon. Data of first five patients with minimum 6 months follow up was analyzed for glycemic control and altered need for medications. Data were analyzed using SPSS (SPSS release 16; SPSS Inc. Chicago). The study target (HbA1c < 7) was achieved in 60% of patients within 1 month and in 100% of patients within 6 months. Requirement of medications reduced significantly within 6 months and their HbA1c levels reduced from 9.65% to 6.22%. Laparoscopic SGIT may represent a new paradigm for the treatment of T2DM even in non morbidly obese patients.
- Banting FG, Best CH. The internal secretion of the pancreas. J Lab Clin Med. 1922;7:251–66.
- Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595–607. CrossRef
- American Diabetes Association. Prevention or delay of type 2 diabetes. Diabetes Care. 2004;27(Suppl):S47–53.
- Singh BM, Jackson DM, Wills R, Davies J, Wise PH. Delayed diagnosis of non–insulin-dependent diabetes. Br Med J. 1992;304:1154–5. CrossRef
- Olefsky J, Nolan J. Insulin resistance and non–insulindependent diabetes mellitus: cellular and molecular mechanisms. Am J Clin Nutr. 1995;61:980S–6S.
- Arner P, Pollare T, Lithell H. Different aetiologies of type 2 (non–insulin-dependent) diabetes mellitus in obese and nonobese subjects. Diabetologia. 1991;34:483–7. CrossRef
- Gerich JE. Insulin resistance is not necessarily an essential component of type 2 diabetes. J Clin Endocrinol Metab. 2000;85:2113–5. CrossRef
- Vilsboll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, et al. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide regardless of etiology and phenotype. J Clin Endocrinol Metab. 2003;88:4897–903. CrossRef
- Luzi L, DeFronzo RA. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol. 1989;257:E241–6.
- Vilsboll T, Holst JJ. Incretins, insulin secretion, and type 2 diabetes mellitus. Diabetologia. 2004;47:357–66. CrossRef
- Zander M, Madsbad S, Madsen JL, Hoslt JJ. Effect of 6- week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta cell function in type 2 diabetes: a parallel-group study. Lancet. 2002;359:824–30. CrossRef
- Hickey MS, Pories WJ, MacDonald Jr m2, Cory KA, Dohm GL, Swanson MS, et al. A new paradigm for type 2 diabetes mellitus? Could it be a disease of the foregut? Ann Surg. 1998;227:637–44. CrossRef
- Greenway SE, Greenway FL, Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002;137:1109–17. CrossRef
- Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoellesk. Bariatic surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–1737. CrossRef
- De Paula AL, Macedo AL, Prudente AS, Queiroz L, Schraibman V, Pinus J. Laparoscopic sleeve gastrectomy with ileal transposition (“neuroendocrine brake”): pilot study of a new operation. Surg Obes Relat Dis. 2006;2:464–7. CrossRef
- Paula AL, Macedo ALV, Rassi N, Machado CA, Schraiban V, Silva LQ, Halpern H. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 2008;22:706–16.
- American Diabetic Association. Standard of Medical Care in Diabetes – 2009. Diabetes Care. 2009;32 suppl 1:S13–61. CrossRef
- King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025; prevalence numerical estimates and projections. Diabetes Care. 1998;21:1414–31.
- Health planning in North-East India: A survey on Diabetes Awareness, Risk Factor and Health Attitudes in a Rural Community Sue.L.Lal, Rati. Debaema, N.Thomas, HS Asha, KS Vasan, RG Alex, JAPI April 2009;57:305–309.
- Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467–84.
- Torquati A, Lutfi R, Abumrad N, et al. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg. 2005;9:1112–8. CrossRef
- Dixon JB, Pories WJ, O’Brien PE, Schauer PR, Zimmet P. Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care. 2005;28:472–4. CrossRef
- Vidal J, Ibarzabal A, Romero F, Delgado S, Mombian D, Flores L, et al. Type 2 Diabetes Mellitus and the metabolic syndrome following Sleeve Gastrectomy in Severely Obese Subjects. Obes Surg. 2008;18:1077–82. CrossRef
- Rask E, Olsson T, Soderberg S, Holst JJ, Tura A, Pacini G, et al. Insulin secretion and incretin hormones after oral glucose in nonobese subjects with impaired glucose tolerance. Metabolism. 2004;53:624–31. CrossRef
- Bedno S. Weight loss in diabetes management. Nutr Clin Care. 2003;6:62–72.
- Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9. CrossRef
- Service GJ, Thompson GB, Service J, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nessidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353:249–52. CrossRef
- John BB, Sonia C, Willam TC, Antonio C, Stefano DP, Silvio EI, et al. How do we define cure of diabetes ? Diabetes Care. 2009;22:2133–5.
- Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23–35 BMI patients
International Journal of Diabetes in Developing Countries
Volume 31, Issue 2 , pp 91-96
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links